These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6164832)

  • 21. [Cox regression analysis of the prognostic factors of unresectable esophageal carcinoma after stenting].
    Fu JH; Rong TH; Li XD; Ma GW; Hu Y; Min HQ
    Ai Zheng; 2003 Jan; 22(1):91-4. PubMed ID: 12561445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Multivariate prognostic analysis for patients with unresectable esophageal carcinoma after concurrent chemoradiotherapy].
    Chen EC; Liu MZ; Hu YH; Li QQ; Liu H; Cai L; Liu H; Lin HX; Huang Y; Wang HY; Cui NJ
    Ai Zheng; 2005 Jun; 24(6):731-4. PubMed ID: 15946490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and alteration of p53 and p21(waf1/cip1) influence the sensitivity of chemoradiation therapy for esophageal cancer.
    Shimoyama S; Konishi T; Kawahara M; Aoki F; Harada N; Shimizu S; Murakami T; Kaminishi M
    Hepatogastroenterology; 1998; 45(23):1497-504. PubMed ID: 9840093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current diagnosis and therapy of esophageal carcinoma].
    Mühr-Wilkenshoff F; Stahl M; Faiss S; Zeitz M; Scherübl H
    Z Gastroenterol; 2004 Jul; 42(7):615-21. PubMed ID: 15248111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic carcinoma mimicking primary thyroid cancer.
    Koutkia P; Safran H; Kahn C
    Med Health R I; 2001 Jun; 84(6):204-6. PubMed ID: 11434152
    [No Abstract]   [Full Text] [Related]  

  • 26. Planned neck dissection after definitive radiotherapy or chemoradiation for base of tongue cancers.
    Hitchcock YJ; Bentz BG; Sharma PK; Fang C; Tward JD; Pappas L; Chen J; Hayes JK; Shrieve DC
    Otolaryngol Head Neck Surg; 2007 Sep; 137(3):422-7. PubMed ID: 17765769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of argyrophilic nucleolar organizer regions (AGNOR) in oesophageal cancer.
    Babu M; Mathur M; Gupta SD; Chattopadhyay TK
    Trop Gastroenterol; 1996; 17(1):57-60. PubMed ID: 8693588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome.
    Wu TT; Chirieac LR; Abraham SC; Krasinskas AM; Wang H; Rashid A; Correa AM; Hofstetter WL; Ajani JA; Swisher SG
    Am J Surg Pathol; 2007 Jan; 31(1):58-64. PubMed ID: 17197919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of pathologic examination in detection of complete response after chemoradiation for esophageal cancer.
    Chang EY; Smith CA; Corless CL; Thomas CR; Hunter JG; Jobe BA
    Am J Surg; 2007 May; 193(5):614-7; discussion 617. PubMed ID: 17434367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early experience with linear accelerator in carcinoma oesophagus middle third.
    Ratnam SV; Baboo HA; Sabir AA; Sharma A; Vyas R
    Indian J Chest Dis Allied Sci; 1986; 28(4):197-201. PubMed ID: 3111992
    [No Abstract]   [Full Text] [Related]  

  • 31. Palliation after operation and after radiotherapy for cancer of the esophagus.
    Stoller JL; Brumwell ML
    Can J Surg; 1984 Sep; 27(5):491-5. PubMed ID: 6206934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative chemotherapy followed by esophagectomy compared with surgery alone in the treatment of squamous cell carcinoma of the esophagus.
    Hernández Lizoain JL; Cienfuegos JA; Pardo F; Martínez Regueira F; Sola I; Aristu J; Azinovic I
    Rev Esp Enferm Dig; 1998 Apr; 90(4):275-90. PubMed ID: 9623271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer.
    Prenzel KL; König A; Schneider PM; Schnickmann C; Baldus SE; Schröder W; Bollschweiler E; Dienes HP; Mueller RP; Izbicki JR; Hölscher AH
    Ann Surg Oncol; 2007 Feb; 14(2):954-9. PubMed ID: 17103071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Squamous-cell carcinoma of the rectum: a rare but curable tumor.
    Nahas CS; Shia J; Joseph R; Schrag D; Minsky BD; Weiser MR; Guillem JG; Paty PB; Klimstra DS; Tang LH; Wong WD; Temple LK
    Dis Colon Rectum; 2007 Sep; 50(9):1393-400. PubMed ID: 17661147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathologic prognostic factors in esophageal squamous cell carcinoma: a follow-up study of 74 patients with or without preoperative chemoradiation therapy.
    Torres CM; Wang HH; Turner JR; Richards W; Sugarbaker D; Shahsafaei A; Odze RD
    Mod Pathol; 1999 Oct; 12(10):961-8. PubMed ID: 10530561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Should adjuvant or neoadjuvant treatment be administered in esophageal cancer?].
    Bedenne L
    Ann Chir; 1997; 51(6):605-10. PubMed ID: 9406457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of tumor overgrowth in esophageal cancer by placement of a second stent: two case reports.
    Ribeiro JC; Gomes DF; Lopes HM; Souto PM; Oliveira e Silva Pontes JM; Gouveia HJ; Leitão MJ; Freitas Dda S
    Hepatogastroenterology; 1996; 43(12):1537-9. PubMed ID: 8975962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neoadjuvant chemoradiotherapy in esophageal cancer].
    Cordiano C; Laterza E; Urso SU; Castaldini G
    Chir Ital; 1994; 46(3):11-5. PubMed ID: 8001187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of oesophageal squamous cell carcinoma in a patient with Fanconi anaemia.
    Tipples K; Raouf S
    Clin Oncol (R Coll Radiol); 2008 Jun; 20(5):383-4. PubMed ID: 18387792
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.